Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB23FBPJ7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,856
Award facts
- Contract value 100% obligated
- $67,856.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $67,856.16 to Amerisourcebergen Drug Corporation for the purchase of Ocrevus 300 MG/10 ML vials. Performance will take place in Conshohocken, Pennsylvania under the prime contractor's corporate office division. The order is associated with DLA's pharmaceutical procurement programs and runs from August 18 to September 11, 2023. No subcontractors or set aside designations were indicated.
Quick answers
Who was awarded contract SPE2DB23FBPJ7?
SPE2DB23FBPJ7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2023.
How much is contract SPE2DB23FBPJ7 worth?
The government has obligated $67,856 on SPE2DB23FBPJ7.
Is contract SPE2DB23FBPJ7 an order under another contract?
Yes. SPE2DB23FBPJ7 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB23FBPJ7 competed?
The extent of competition for SPE2DB23FBPJ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award